Tuesday, 02 January 2024 12:17 GMT

M1 Kliniken AG: Capital Reduction Through Cancellation Of Treasury Shares Successfully Completed


(MENAFN- EQS Group)
M1 Kliniken AG / Key word(s): Corporate Action
M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
26.05.2026 / 16:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed Berlin, 26 May 2026 M1 Kliniken AG (ISIN DE000A0STSQ8) has cancelled the treasury shares acquired under its share buyback programme and reduced its share capital accordingly. On 25 March 2026, the Management Board resolved, with the approval of the Supervisory Board granted on 26 March 2026 and on the basis of the authorisation by the Annual General Meeting of 17 July 2024, to reduce the Company's share capital by EUR 1,088,289 from EUR 19,643,403 to EUR 18,555,114. The capital reduction became effective upon registration in the commercial register of the Local Court of Charlottenburg (HRB 107637 B) on 26 May 2026. The cancellation was carried out under the simplified procedure pursuant to Section 237 (3) no. 3 of the German Stock Corporation Act (AktG). The Articles of Association were amended accordingly in Section II. 4. (Amount and Division of the Share Capital). About M1 Kliniken AG M1 Kliniken AG is the leading fully integrated provider of medical aesthetic services in Europe and Australia. With a clear strategic focus, high standardisation, and consistent scalability, the Group currently operates 59 clinics in ten countries under the M1 Med Beauty brand. All treatments are performed exclusively by qualified physicians and adhere to uniform, high medical standards, while being offered at market-leading prices. Since late 2018, M1 has systematically driven its international expansion, which forms the basis for scalable future growth and the further development of its global market position. With the M1 Schlossklinik in Berlin, the Group operates one of Europe's largest and most modern clinics for plastic and aesthetic surgery, featuring four operating theatres and 35 beds.
Contact: M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
T: +49 (0)30 347 47 44 14
M:... 26.05.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Language: English
Company: M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: +49 (0)30 347 47 44 14
Fax: +49 (0)30 347 47 44 17
E-mail: ...
Internet:
ISIN: DE000A0STSQ8
WKN: A0STSQ
Listed: Regulated Unofficial Market in Dusseldorf, Frankfurt (Basic Board), Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX
EQS News ID: 2333736

End of News EQS News Service

2333736 26.05.2026 CET/CEST

MENAFN26052026004691010666ID1111169781



EQS Group

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search